Page 5 - Pharma Services News Today

Mitsubishi UFJ Asset Management UK Ltd. lifted its holdings in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 13.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 41,000 shares of the medical research company’s stock after acquiring an additional 5,000 shares during the quarter. […]

/PRNewswire/ -- The pharmaceutical contract research and manufacturing (CRAM) market is expected to grow by USD 121.35 billion from 2022 to 2027. In addition,...

/PRNewswire/ -- The "Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics),...

NeoGenomics (NASDAQ:NEO – Get Free Report) and Applied DNA Sciences (NASDAQ:APDN – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings. Profitability This table compares NeoGenomics and Applied […]

Emerald Advisers LLC raised its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 16.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,927,074 shares of the medical research company’s stock after acquiring an additional 270,855 shares during the period. NeoGenomics comprises about […]

Applied DNA Sciences (NASDAQ:APDN – Get Free Report) and NeoGenomics (NASDAQ:NEO – Get Free Report) are both industrial products companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends and earnings. Insider & Institutional Ownership 17.3% of Applied […]

NeoGenomics (NASDAQ:NEO – Get Free Report) and Applied DNA Sciences (NASDAQ:APDN – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings. Profitability This table compares NeoGenomics and Applied […]

/PRNewswire/ -- The pharmaceutical contract manufacturing market is expected to grow by USD 58 billion from 2022 to 2027. In addition, the momentum of the...

Thermo Fisher Scientific to provide CAR-T manufacturing and kitting services for Galapagos’ point-of-care CAR-T product candidate in the San Francisco areaAgreement follows previously announced...

NeoGenomics (NASDAQ:NEO – Free Report) had its price objective decreased by BTIG Research from $25.00 to $21.00 in a research note published on Friday morning, MarketBeat reports. BTIG Research currently has a buy rating on the medical research company’s stock. Several other equities research analysts also recently commented on the company. StockNews.com assumed coverage on […]